A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

Background: Reducing glycemic fluctuation is important for optimal diabetes management. This post hoc analysis examined glycemic fluctuations and the proportion of subjects achieving recommended blood glucose targets with the fixed ratio combination of insulin degludec and liraglutide (IDegLira) com...

Descripción completa

Detalles Bibliográficos
Autores principales: King, Allen B., Philis-Tsimikas, Athena, Kilpatrick, Eric S., Langbakke, Irene H., Begtrup, Kamilla, Vilsbøll, Tina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399738/
https://www.ncbi.nlm.nih.gov/pubmed/28282219
http://dx.doi.org/10.1089/dia.2016.0405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399738/
https://www.ncbi.nlm.nih.gov/pubmed/28282219
http://dx.doi.org/10.1089/dia.2016.0405

Ejemplares similares